Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03521362 · ClinicalTrials.gov registry record · NA

MyT1DHero: an mHealth Intervention for Type 1 Diabetes

A NA study of Type1diabetes, sponsored by Michigan State University.

Completed
Registry status
NA
Development phase
33
Enrollment target
1
Study location

NCT03521362 is a NA study of Type1diabetes that has completed, run by Michigan State University. The registered enrollment target is 33 participants, below the 260-participant average among 19 other Type1diabetes trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03521362, a NA study of Type1diabetes, has completed, sponsored by Michigan State University.

COMPLETED
Registry status
NA
Development phase
33 participants
Enrollment target
1
Study location

Study Summary

The overall objective of the proposed research is to improve HbA1c, adherence to treatment plans, and family communication surrounding adolescents' self-management of T1D. The investigators will test the efficacy of the MyT1DHero app against an attention control group. This will allow investigators to better understand the health and psychosocial improvements being made through the app.

Conditions Studied

Type1diabetes

Interventions

  • DEVICE MyT1DHero
  • DEVICE Other T1D Mobile App

Study Locations (1)

Michigan

  • Michigan State University - East Lansing

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2019-01-01
Est. Completion 2021-12-01
Phase NA

Sponsor

Michigan State University

120 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03521362

The ClinicalTrials.gov registry entry for NCT03521362 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 260-participant average among 19 other Type1diabetes trials with a reported enrollment target (87% lower). The listed sponsor is Michigan State University, which has 120 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type1diabetes appearing as the primary indexed condition, and to 2 interventions - of which MyT1DHero is the first listed.

NCT03521362 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT03521362 about?

NCT03521362 is a clinical study titled "MyT1DHero: an mHealth Intervention for Type 1 Diabetes". The overall objective of the proposed research is to improve HbA1c, adherence to treatment plans, and family communication surrounding adolescents' self-management of T1D. The investigators will test the efficacy of the MyT1DHero app against an attention control group. This will allow investigators ...

What is the current status of trial NCT03521362?

This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2019-01-01. Estimated completion is 2021-12-01.

What conditions does trial NCT03521362 study?

This clinical trial studies the following conditions: Type1diabetes.

What interventions are being tested in trial NCT03521362?

The interventions under investigation include: MyT1DHero (DEVICE), Other T1D Mobile App (DEVICE).

Who is sponsoring clinical trial NCT03521362?

This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03521362 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Type1diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Type1diabetes

All registered trials for this condition

Michigan

All trials with a study site in Michigan

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.